Myriad Genetics (MYGN) Cash from Operations Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 14.65% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 45.83% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 25.34% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 25.96% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 86.90% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -14.10% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 31.33% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -28.21% |
| 10 | Myriad Genetics | 300.99 Mn | 185.79 Mn | 127.00 Mn | 38.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.97% |
| Mar 31, 2026 | 3.68% |
| Dec 31, 2025 | 60.61% |
| Sep 30, 2025 | 2,914.29% |
| Jun 30, 2025 | -623.08% |
| Mar 31, 2025 | 12.37% |
| Dec 31, 2024 | 112.07% |
| Sep 30, 2024 | 103.17% |
| Jun 30, 2024 | 388.89% |
| Mar 31, 2024 | 43.98% |
| Dec 31, 2023 | -649.32% |
| Sep 30, 2023 | -689.29% |
| Jun 30, 2023 | 98.19% |
| Mar 31, 2023 | 28.60% |
| Dec 31, 2022 | 23.16% |
| Sep 30, 2022 | 92.88% |
| Jun 30, 2022 | -1,029.55% |
| Mar 31, 2022 | -164.76% |
| Dec 31, 2021 | 87.11% |
| Sep 30, 2021 | 33.73% |